mitoxantrone has been researched along with Hyperuricemia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The first-line treatment of hyperuricemia, which causes gout, is allopurinol." | 4.91 | Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. ( Banda, Y; Giacomini, KM; Hoffmann, TJ; Jorgenson, E; Kvale, MN; Liang, X; Risch, N; Schaefer, C; Wen, CC; Yee, SW, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, CC | 1 |
| Yee, SW | 1 |
| Liang, X | 1 |
| Hoffmann, TJ | 1 |
| Kvale, MN | 1 |
| Banda, Y | 1 |
| Jorgenson, E | 1 |
| Schaefer, C | 1 |
| Risch, N | 1 |
| Giacomini, KM | 1 |
1 review available for mitoxantrone and Hyperuricemia
| Article | Year |
|---|---|
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Topics: Aged; Allopurinol; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Tra | 2015 |